STOCKWATCH
·
Pharmaceuticals
USFDA19 Apr 2024, 11:11 pm

Laurus Labs Ltd: Successful USFDA Inspection of API Manufacturing Facilities

AI Summary

Laurus Labs Ltd has announced the successful completion of a USFDA inspection of their API manufacturing facilities, Units-1 and -3, in Parawada, Anakapalli, Andhra Pradesh. The inspection, which took place from 15th to 19th April, 2024, did not result in any 483 observations.

Key Highlights

  • Laurus Labs Ltd undergoes USFDA inspection
  • Inspection held in Parawada, Andhra Pradesh
  • No 483 observations during the inspection
  • Units-1 and -3 inspected in Laurus Labs' API manufacturing facilities
LAURUSLABS
Pharmaceuticals
Laurus Labs Ltd

Price Impact